127 related articles for article (PubMed ID: 24366844)
1. Comparison of serum fatty acid concentrations in cats with hypertrophic cardiomyopathy and healthy controls.
Hall DJ; Freeman LM; Rush JE; Cunningham SM
J Feline Med Surg; 2014 Aug; 16(8):631-6. PubMed ID: 24366844
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of red blood cell distribution width in cats with hypertrophic cardiomyopathy.
Stanzani G; Cowlam R; English K; Connolly DJ
J Vet Cardiol; 2015 Dec; 17 Suppl 1():S233-43. PubMed ID: 26776582
[TBL] [Abstract][Full Text] [Related]
3. Plasma growth differentiation factors 8 and 11 levels in cats with congestive heart failure secondary to hypertrophic cardiomyopathy.
Yang VK; Rush JE; Bhasin S; Wagers AJ; Lee RT
J Vet Cardiol; 2019 Oct; 25():41-51. PubMed ID: 31568985
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of coagulation markers in the plasma of healthy cats and cats with asymptomatic hypertrophic cardiomyopathy.
Bédard C; Lanevschi-Pietersma A; Dunn M
Vet Clin Pathol; 2007 Jun; 36(2):167-72. PubMed ID: 17523090
[TBL] [Abstract][Full Text] [Related]
5. N-terminal atrial natriuretic peptide immunoreactivity in plasma of cats with hypertrophic cardiomyopathy.
MacLean HN; Abbott JA; Ward DL; Huckle WR; Sisson DD; Pyle RL
J Vet Intern Med; 2006; 20(2):284-9. PubMed ID: 16594584
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of morphometric measurements and serum insulin-like growth factor concentration in healthy cats and cats with hypertrophic cardiomyopathy.
Yang VK; Freeman LM; Rush JE
Am J Vet Res; 2008 Aug; 69(8):1061-6. PubMed ID: 18672971
[TBL] [Abstract][Full Text] [Related]
7. Magnesium status and the effect of magnesium supplementation in feline hypertrophic cardiomyopathy.
Freeman LM; Brown DJ; Smith FW; Rush JE
Can J Vet Res; 1997 Jul; 61(3):227-31. PubMed ID: 9243004
[TBL] [Abstract][Full Text] [Related]
8. Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats.
Wess G; Daisenberger P; Mahling M; Hirschberger J; Hartmann K
Vet Clin Pathol; 2011 Jun; 40(2):237-44. PubMed ID: 21434959
[TBL] [Abstract][Full Text] [Related]
9. Cardiac troponin I in cats with hypertrophic cardiomyopathy.
Connolly DJ; Cannata J; Boswood A; Archer J; Groves EA; Neiger R
J Feline Med Surg; 2003 Aug; 5(4):209-16. PubMed ID: 12878148
[TBL] [Abstract][Full Text] [Related]
10. Cardiac troponin I in feline hypertrophic cardiomyopathy.
Herndon WE; Kittleson MD; Sanderson K; Drobatz KJ; Clifford CA; Gelzer A; Summerfield NJ; Linde A; Sleeper MM
J Vet Intern Med; 2002; 16(5):558-64. PubMed ID: 12322706
[TBL] [Abstract][Full Text] [Related]
11. Effect of feline characteristics on plasma N-terminal-prohormone B-type natriuretic peptide concentration and comparison of a point-of-care test and an ELISA test.
Hanås S; Holst BS; Höglund K; Häggström J; Tidholm A; Ljungvall I
J Vet Intern Med; 2020 May; 34(3):1187-1197. PubMed ID: 32200578
[TBL] [Abstract][Full Text] [Related]
12. Plasma cardiac troponin I concentration and cardiac death in cats with hypertrophic cardiomyopathy.
Borgeat K; Sherwood K; Payne JR; Luis Fuentes V; Connolly DJ
J Vet Intern Med; 2014; 28(6):1731-7. PubMed ID: 25319115
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of cardiac troponin I in cats with hypertrophic cardiomyopathy.
Hori Y; Iguchi M; Heishima Y; Yamashita Y; Nakamura K; Hirakawa A; Kitade A; Ibaragi T; Katagi M; Sawada T; Yuki M; Kanno N; Inaba H; Isayama N; Onodera H; Iwasa N; Kino M; Narukawa M; Uchida S
J Vet Intern Med; 2018 May; 32(3):922-929. PubMed ID: 29660794
[TBL] [Abstract][Full Text] [Related]
14. Symmetric Dimethylarginine in Cats with Hypertrophic Cardiomyopathy and Diabetes Mellitus.
Langhorn R; Kieler IN; Koch J; Christiansen LB; Jessen LR
J Vet Intern Med; 2018 Jan; 32(1):57-63. PubMed ID: 29230874
[TBL] [Abstract][Full Text] [Related]
15. Echocardiographic Assessment of Right Ventricular Size and Function in Cats With Hypertrophic Cardiomyopathy.
Visser LC; Sloan CQ; Stern JA
J Vet Intern Med; 2017 May; 31(3):668-677. PubMed ID: 28295648
[TBL] [Abstract][Full Text] [Related]
16. Mitral Annular Plane Systolic Excursion and Tricuspid Annular Plane Systolic Excursion in Cats with Hypertrophic Cardiomyopathy.
Spalla I; Payne JR; Borgeat K; Pope A; Fuentes VL; Connolly DJ
J Vet Intern Med; 2017 May; 31(3):691-699. PubMed ID: 28370313
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant defence and oxidative stress markers in cats with asymptomatic and symptomatic hypertrophic cardiomyopathy: a pilot study.
Michałek M; Tabiś A; Pasławska U; Noszczyk-Nowak A
BMC Vet Res; 2020 Jan; 16(1):26. PubMed ID: 32000761
[TBL] [Abstract][Full Text] [Related]
18. ProANP as a screening biomarker for hypertrophic cardiomyopathy in Maine coon cats.
Parzeniecka-Jaworska M; Garncarz M; Kluciński W
Pol J Vet Sci; 2016 Dec; 19(4):801-807. PubMed ID: 28092607
[TBL] [Abstract][Full Text] [Related]
19. The effect of atenolol on NT-proBNP and troponin in asymptomatic cats with severe left ventricular hypertrophy because of hypertrophic cardiomyopathy: a pilot study.
Jung SW; Kittleson MD
J Vet Intern Med; 2011; 25(5):1044-9. PubMed ID: 21781160
[TBL] [Abstract][Full Text] [Related]
20. Platelet activation in cats with hypertrophic cardiomyopathy.
Tablin F; Schumacher T; Pombo M; Marion CT; Huang K; Norris JW; Jandrey KE; Kittleson MD
J Vet Intern Med; 2014; 28(2):411-8. PubMed ID: 24612013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
